// STATE LEGISLATION TRACKER

Oregon HB 4142: Relating to marijuana for medical use; and prescribing an effective date.

⚖️ NEUTRAL for peptide users 👤 NONE user impact 📜 Status: Signed

State: Oregon
Bill: HB 4142
Session: 2026R1
Filed: 2026-02-02
Read the bill: OpenStates →
Last reviewed: 2026-10-02

Plain-English Summary

Oregon HB4142 is a medical marijuana law, not a peptide or compounding bill. Based on the title, summary, and status, it does not appear to change access to compounded peptides, off-label peptide prescribing, telehealth peptide care, FDA 503A/503B compounding, controlled substances rules, or prescription monitoring.

Key Points

No apparent change to compounded peptide access in Oregon
No apparent change to off-label peptide prescribing rules
No apparent change to NP or naturopath peptide prescribing scope
No apparent change to 503A or 503B compounding rules
Nursing protection appears limited to discussing medical marijuana

What to Watch For

Note Clinicians should treat this as cannabis-specific unless later rules expand into broader prescribing conduct.

Note Residential care policies may change for medical marijuana, but not for peptide therapies.

✓

Opportunity The nursing-board language may signal comfort with patient counseling, but it is not peptide-specific.

Where the Bill Stands

HB4142 was signed by the Governor and assigned Chapter 118, with an effective date of June 5, 2026.

· Ed. Our analysis pulls public bill metadata from OpenStates and is enriched with research-model context. We don't quote bill text we haven't read directly. If this bill matters to your practice or treatment access, read the official source linked above before taking action. We're an educational research directory, not a legal or medical reference.

Bill page generated 2026-11-04 · enriched via codex gpt-5.5
Source: OpenStates v3 API · View official bill · ← back to all laws